Aktiesnakken — December 2019
-
Orphazyme får eftertragtet status hos FDA til Arimoclomol
-
waturu i 40 nu ned med 60% på en uge....Og faldet stopper ikke der. Den er stadig massivt overvurderet
-
Ved lagerbeskatning skal du ikke gøre noget. Skattevæsenet hæver skat af det dit depot er vokset, uanset om du har solgt noget eller ej.
-
1
-
WSJ Markets
@WSJmarkets
·
22 min
European government bond yields rally after Sweden’s exit from negative interest rates prompted speculation that other central banks might be deterred from dropping below zero -
WSJ Markets
@WSJmarkets
U.S. government bond prices rose amid mixed economic data -
U.S. Food and Drug Administration granted accelerated approval to Padcev (enfortumab vedotin-ejfv), a Nectin-4-directed antibody and microtubule inhibitor conjugate, meaning the drug specifically targets cancer cells – in this case, the cell adhesion molecule Nectin-4, which is highly expressed in urothelial cancers. https://www.fda.gov/news-events/press-announcements/fda-approves-new-type-therapy-treat-advanced-urothelial-cancer
)
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind